 |
|
Etanercept for steroid-refractory acute graft versus host disease following allogeneic hematopoietic stem cell transplantation
Joo Han Park, Hyo Jung Lee, Sei Rhan Kim, Ga Won Song, Seung Kyong Lee, Sun Young Park, Ki Chan Kim, Sun Hyuk Hwang, Joon Seong Park
Korean J Intern Med. 2014;29(5):630-636. Published online 2014 Aug 28 DOI: https://doi.org/10.3904/kjim.2014.29.5.630
|
|
Citations to this article as recorded by
 Basiliximab Treatment for Patients With Steroid-Refractory Acute Graft-Versus-Host Disease Following Matched Sibling Donor Hematopoietic Stem Cell Transplantation
Xin-Ya Jiang, Xiao-Hui Zhang, Lan-Ping Xu, Yu Wang, Chen-Hua Yan, Huan Chen, Yu-Hong Chen, Wei Han, Feng-Rong Wang, Jing-Zhi Wang, Yu-Qian Sun, Xiao-Dong Mo, Xiao-Jun Huang
Cell Transplantation.2024;[Epub] CrossRef Diagnostic, prophylaxie et prise en charge thérapeutique de la GVH aiguë : recommandations de la SFGM-TC
Laetitia Souchet, Stavroula Masouridi, Ambroise Marçais, Ahmad Ibrahim, Celine Chauvel, Eric Turquet, Marion Derail, Ibrahim Yakoub-Agha, Roberto Crocchiolo
Bulletin du Cancer.2023; 110(2): S79. CrossRef Hepatic graft-versus-host disease: what we know, when to biopsy, and how to diagnose
Ashley E. Stueck, M. Isabel Fiel
Human Pathology.2023; 141: 170. CrossRef Understanding and treatment of cutaneous graft-versus-host-disease
Junshik Hong, Johnathan Fraebel, Yenny Yang, Eric Tkacyk, Carrie Kitko, Tae Kon Kim
Bone Marrow Transplantation.2023; 58(12): 1298. CrossRef Novel therapies for graft versus host disease with a focus on cell therapies
Robert Zeiser, Olle Ringden, Behnam Sadeghi, Gil Gonen-Yaacovi, Oscar G. Segurado
Frontiers in Immunology.2023;[Epub] CrossRef Established and Emerging Treatments of Skin GvHD
Cornelia S. Link-Rachner, Katja Sockel, Catharina Schuetz
Frontiers in Immunology.2022;[Epub] CrossRef Efficacy and safety of ruxolitinib in steroid-refractory graft-versus-host disease: A meta-analysis
Shuang Fan, Wen-Xuan Huo, Yang Yang, Meng-Zhu Shen, Xiao-Dong Mo
Frontiers in Immunology.2022;[Epub] CrossRef Immunomodulatory Therapies for the Treatment of Graft-versus-host Disease
Lukas M. Braun, Robert Zeiser
HemaSphere.2021; 5(6): e581. CrossRef Mesenchymal Stromal Cells for the Treatment of Graft Versus Host Disease
Kilian Kelly, John E. J. Rasko
Frontiers in Immunology.2021;[Epub] CrossRef Worldwide Network for Blood and Marrow Transplantation (WBMT) perspective: the role of biosimilars in hematopoietic cell transplant: current opportunities and challenges in low- and lower-middle income countries
Ibrahim N. Muhsen, Shahrukh K. Hashmi, Dietger Niederwieser, Nicolaus Kroeger, Samir Agrawal, Marcelo C. Pasquini, Yoshiko Atsuta, Karen K. Ballen, Adriana Seber, Wael Saber, Mohamed A. Kharfan-Dabaja, Walid Rasheed, Shinichiro Okamoto, Nandita Khera, Wil
Bone Marrow Transplantation.2020; 55(4): 698. CrossRef Graft‐Versus‐Host Disease After Liver Transplantation
Ashley Wood, Bijan Eghtesad, Christina C. Lindenmeyer
Clinical Liver Disease.2020; 15(2): 81. CrossRef Treatment and unmet needs in steroid-refractory acute graft-versus-host disease
Florent Malard, Xiao-Jun Huang, Joycelyn P. Y. Sim
Leukemia.2020; 34(5): 1229. CrossRef Ruxolitinib combined with etanercept induce a rapid response to corticosteroid‐refractory severe acute graft vs host disease after allogeneic stem cell transplantation: Results of a multi‐center prospective study
Yanmin Zhao, Hengwei Wu, Jimin Shi, Yi Luo, Xiaoqing Li, Jianping Lan, Wanmao Ni, Ying Lu, Lieguang Chen, Yamin Tan, Xiaoyu Lai, Jian Yu, He Huang
American Journal of Hematology.2020; 95(9): 1075. CrossRef Production, safety and efficacy of iPSC-derived mesenchymal stromal cells in acute steroid-resistant graft versus host disease: a phase I, multicenter, open-label, dose-escalation study
Adrian J. C. Bloor, Amit Patel, James E. Griffin, Maria H. Gilleece, Rohini Radia, David T. Yeung, Diana Drier, Laurie S. Larson, Gene I. Uenishi, Derek Hei, Kilian Kelly, Igor Slukvin, John E. J. Rasko
Nature Medicine.2020; 26(11): 1720. CrossRef Etanercept as Treatment of Steroid-Refractory Acute Graft-versus-Host Disease in Pediatric Patients
Maura Faraci, Maria Grazia Calevo, Stefano Giardino, Massimiliano Leoni, Erica Ricci, Elio Castagnola, Edoardo Lanino
Biology of Blood and Marrow Transplantation.2019; 25(4): 743. CrossRef Safety and Effectiveness of Vedolizumab in Patients with Steroid-Refractory Gastrointestinal Acute Graft-versus-Host Disease: A Retrospective Record Review
Yngvar Fløisand, Vladimir Lj Lazarevic, Johan Maertens, Jonas Mattsson, Nirav N. Shah, Pierre Zachée, Aliki Taylor, Mona Akbari, Syed Quadri, Andrejus Parfionovas, Yi-Bin Chen
Biology of Blood and Marrow Transplantation.2019; 25(4): 720. CrossRef Targeting Regulatory T Cells by Addressing Tumor Necrosis Factor and Its Receptors in Allogeneic Hematopoietic Cell Transplantation and Cancer
Harald Wajant, Andreas Beilhack
Frontiers in Immunology.2019;[Epub] CrossRef Treatment with etanercept and low monocyte concentration contribute to the risk of invasive aspergillosis in patients post allogeneic stem cell transplantation
Tamara Zoran, Michael Weber, Jan Springer, P. Lewis White, Joachim Bauer, Annika Schober, Claudia Löffler, Bastian Seelbinder, Kerstin Hünniger, Oliver Kurzai, André Scherag, Sascha Schäuble, C. Oliver Morton, Hermann Einsele, Jörg Linde, Jürgen Löffler
Scientific Reports.2019;[Epub] CrossRef Tumor Necrosis Factor α and Regulatory T Cells in Oncoimmunology
Benoît L. Salomon, Mathieu Leclerc, Jimena Tosello, Emilie Ronin, Eliane Piaggio, José L. Cohen
Frontiers in Immunology.2018;[Epub] CrossRef Advance in Targeted Immunotherapy for Graft-Versus-Host Disease
Lingling Zhang, Jianhua Yu, Wei Wei
Frontiers in Immunology.2018;[Epub] CrossRef Poor prognosis in patients with steroid refractory acute graft versus host disease treated with etanercept: a multi-centre analysis
Chun Kei Kris Ma, Irene García-Cadenas, María Laura Fox, Sylvia Ai, Ian Nivison-Smith, Samuel Thomas Milliken, Anthony Dodds, Keith Fay, David D. F. Ma, Rodrigo Martino, Jorge Sierra, John Moore
Bone Marrow Transplantation.2018; 53(11): 1478. CrossRef Off-Label uses of Biologic Agents Approved for Psoriasis and Psoriatic Arthritis for Dermatological Conditions: Part II
Amira Elbendary, Roselyn Kellen
Journal of Psoriasis and Psoriatic Arthritis.2017; 2(2): 65. CrossRef Insurance approval of mesenchymal stem cell for acute GVHD in Japan: need of follow up for some remaining concerns
Koichi Miyamura
International Journal of Hematology.2016; 103(2): 155. CrossRef Therapeutic targets and emerging treatment options in gastrointestinal acute graft-versus-host disease
Anne S. Renteria, John E. Levine, James L. M. Ferrara
Expert Opinion on Orphan Drugs.2016; 4(5): 469. CrossRef Extracorporeal photopheresis and anticytokine therapy in the treatment of steroid-refractory acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation in children
Andrey V Kozlov, Julia G Fedukova, Tatzana A Bykova, Ivan S Moiseev, Marya A Estrina, Irina I Kulagina, Sergey N Bondarenko, Elena V Morozova, Anna A Osipova, Anastasya S Borovkova, Svetlana V Razumova, Ludmila S Zubarovskaya, Boris V Afanasyev
Pediatrician (St. Petersburg).2016; 7(1): 58. CrossRef Ruxolitinib in steroid refractory graft-vs.-host disease: a case report
Enrico Maffini, Luisa Giaccone, Moreno Festuccia, Lucia Brunello, Ilaria Buondonno, Dario Ferrero, Mario Boccadoro, Chiara Dellacasa, Alessandro Busca, Domenico Novero, Benedetto Bruno
Journal of Hematology & Oncology.2016;[Epub] CrossRef Graft Versus Host Disease After Liver Transplantation in Adults
Arvind R. Murali, Subhash Chandra, Zoe Stewart, Bruce R. Blazar, Umar Farooq, M. Nedim Ince, Jeffrey Dunkelberg
Transplantation.2016; 100(12): 2661. CrossRef
|